我国年内已批准创新医疗器械产品52个，医疗器械指数ETF（159898）盘中再获千万资金增仓

Core Viewpoint - The medical device sector is experiencing a positive trend, supported by government policies and innovation in technology, particularly in AI and robotics, which are expected to drive long-term investment opportunities [1][2]. Group 1: Market Performance - On August 26, the three major stock indices continued to rise, with the medical device index ETF (159898) experiencing a slight decline of 0.32% in the afternoon [1]. - The ETF saw an inflow of funds amounting to 10 million, indicating a sustained trend of capital accumulation [1]. Group 2: Regulatory and Policy Support - The National Medical Products Administration (NMPA) has approved 52 innovative medical device products this year, bringing the total to 367 [1]. - The NMPA has introduced ten measures to support key areas in medical device innovation, including medical robotics, high-end medical imaging, AI medical devices, and new biological materials [1]. Group 3: Industry Outlook - The AI wave is expected to catalyze multi-dimensional development in the industry, transitioning from scale expansion to higher-level development stages [1]. - The industry is anticipated to benefit from enhanced health awareness among the public and ongoing consumption stimulus policies, particularly for innovative ophthalmic and home medical device companies [2]. - The impact of centralized procurement is gradually being digested, with increasing domestic market share in orthopedic consumables and electrophysiology [2].